• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子泵抑制剂减量患者教育材料的适宜性:重点综述。

Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review.

机构信息

Department of General Practice, Faculty of Medicine, University of Nantes, Nantes, France.

出版信息

Eur J Clin Pharmacol. 2020 Jan;76(1):17-21. doi: 10.1007/s00228-019-02779-x. Epub 2019 Nov 6.

DOI:10.1007/s00228-019-02779-x
PMID:31690956
Abstract

PURPOSE

Engaging patients in the process of deprescribing is a necessity. Several patient education materials have been developed for this purpose. The aim of this study was to assess the suitability of the existing patient education materials for proton-pump inhibitors deprescribing.

METHODS

We conducted a targeted inventory of the available materials on scientific literature and known repositories. We evaluated their suitability with the Suitability Assessment of Materials (SAM) instrument. Materials were rated independently by two researchers and then discussed until consensus was reached.

RESULTS

Seven patient education materials were identified. Three materials (42.9%) were deemed "superior" and 4 (57.1%) were deemed "adequate". Ratings were generally good in the categories of content, learning stimulation, motivation, typography and layout. The major weaknesses included the use of inappropriate graphics and the too demanding required reading grade level. These may decrease patient attention and comprehension and therefore the effectiveness of education materials.

CONCLUSIONS

Suitability of the patient education materials on proton-pump inhibitors deprescribing is overall satisfactory. Greater attention on readability, graphics and inclusion of summaries will be needed for development of future materials.

摘要

目的

让患者参与到减药过程中是必要的。为此已经开发了一些患者教育材料。本研究旨在评估现有的质子泵抑制剂减药患者教育材料的适用性。

方法

我们在科学文献和已知存储库中进行了有针对性的库存调查。我们使用材料适宜性评估工具(SAM)对其进行了评估。两名研究人员对材料进行了独立评估,然后进行了讨论,直到达成共识。

结果

确定了 7 种患者教育材料。其中 3 种(42.9%)被评为“优秀”,4 种(57.1%)被评为“合格”。在内容、学习激励、动机、排版和布局方面的评价普遍较好。主要弱点包括使用不适当的图形和要求阅读的年级水平过高。这可能会降低患者的注意力和理解能力,从而降低教育材料的有效性。

结论

质子泵抑制剂减药患者教育材料的适用性总体上令人满意。在开发未来的材料时,需要更加关注可读性、图形和摘要的纳入。

相似文献

1
Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review.质子泵抑制剂减量患者教育材料的适宜性:重点综述。
Eur J Clin Pharmacol. 2020 Jan;76(1):17-21. doi: 10.1007/s00228-019-02779-x. Epub 2019 Nov 6.
2
Development of Patient Education Material for Proton Pump Inhibitor Deprescribing: A Mixed-Methods Study.质子泵抑制剂减药患者教育材料的开发:一项混合方法研究。
Ann Pharmacother. 2022 Jul;56(7):800-808. doi: 10.1177/10600280211046630. Epub 2021 Sep 23.
3
Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.多层面干预措施降低初级保健中质子泵抑制剂使用率的效果:基于人群的实用、群组随机对照试验方案。
BMC Health Serv Res. 2022 Feb 17;22(1):219. doi: 10.1186/s12913-022-07496-3.
4
The readability and suitability of sexual health promotion leaflets.性健康促进宣传册的可读性与适用性。
Patient Educ Couns. 2016 Feb;99(2):284-6. doi: 10.1016/j.pec.2015.09.003. Epub 2015 Oct 9.
5
Readability, suitability, and health content assessment of web-based patient education materials on colorectal cancer screening.基于网络的结直肠癌筛查患者教育材料的可读性、适宜性和健康内容评估。
Gastrointest Endosc. 2014 Aug;80(2):284-90. doi: 10.1016/j.gie.2014.01.034. Epub 2014 Mar 25.
6
Availability and readability of patient education materials for deprescribing: An environmental scan.药物减量患者教育材料的可及性和可读性:环境扫描。
Br J Clin Pharmacol. 2019 Jul;85(7):1396-1406. doi: 10.1111/bcp.13912. Epub 2019 May 7.
7
We have had a gutful: The need for deprescribing proton pump inhibitors.我们受够了:减少质子泵抑制剂处方的必要性。
J Clin Pharm Ther. 2018 Feb;43(1):65-72. doi: 10.1111/jcpt.12613. Epub 2017 Sep 11.
8
Deprescribing in a family health team: a study of chronic proton pump inhibitor use.家庭健康团队中的减药:一项关于慢性质子泵抑制剂使用情况的研究。
J Prim Health Care. 2016 Jun;8(2):164-71. doi: 10.1071/HC15946.
9
Evidence-based deprescribing of proton pump inhibitors in long-term care.长期护理中基于证据的质子泵抑制剂减停用药
Res Social Adm Pharm. 2018 Feb;14(2):124-126. doi: 10.1016/j.sapharm.2017.04.001. Epub 2017 Apr 12.
10
Deprescribing proton pump inhibitors: A study in hospitalized patients in Slovenia.停用质子泵抑制剂:斯洛文尼亚住院患者研究。
Int J Clin Pharmacol Ther. 2023 Jul;61(7):306-314. doi: 10.5414/CP204374.

引用本文的文献

1
Development and validation of a training course on proton pump inhibitor deprescription for general practitioners in a rural continuing medical education program: a pilot study.开发并验证质子泵抑制剂减量处方在农村继续医学教育项目中用于全科医生培训课程:一项试点研究。
BMC Med Educ. 2024 Oct 27;24(1):1221. doi: 10.1186/s12909-024-06215-2.
2
Prescription Appropriateness of Drugs for Peptic Ulcer and Gastro-Esophageal Reflux Disease: Baseline Assessment in the LAPTOP-PPI Cluster Randomized Trial.消化性溃疡和胃食管反流病药物的处方适宜性:LAPTOP-PPI 整群随机试验的基线评估
Front Pharmacol. 2022 Mar 28;13:803809. doi: 10.3389/fphar.2022.803809. eCollection 2022.

本文引用的文献

1
Availability and readability of patient education materials for deprescribing: An environmental scan.药物减量患者教育材料的可及性和可读性:环境扫描。
Br J Clin Pharmacol. 2019 Jul;85(7):1396-1406. doi: 10.1111/bcp.13912. Epub 2019 May 7.
2
Continuation or deprescribing of proton pump inhibitors: A consult patient decision aid.质子泵抑制剂的继续使用或停用:一份供咨询患者的决策辅助工具。
Can Pharm J (Ott). 2018 Dec 17;152(1):18-22. doi: 10.1177/1715163518816719. eCollection 2019 Jan-Feb.
3
Can supporting health literacy reduce medication-related harm in older adults?
提高健康素养能否减少老年人用药相关危害?
Ther Adv Drug Saf. 2018 Mar;9(3):167-170. doi: 10.1177/2042098618754482. Epub 2018 Feb 9.
4
Proton Pump Inhibitors and Cardiovascular Events: A Systematic Review.质子泵抑制剂与心血管事件:一项系统评价
Heart Lung Circ. 2018 Apr;27(4):443-450. doi: 10.1016/j.hlc.2017.10.020. Epub 2017 Nov 20.
5
A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.在“增强能力”试验中对患者减药决策的现实主义评价。
BMJ Open. 2017 May 4;7(4):e015959. doi: 10.1136/bmjopen-2017-015959.
6
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
Cochrane Database Syst Rev. 2017 Apr 12;4(4):CD001431. doi: 10.1002/14651858.CD001431.pub5.
7
Deprescribing versus continuation of chronic proton pump inhibitor use in adults.成人慢性质子泵抑制剂的撤药与继续用药对比
Cochrane Database Syst Rev. 2017 Mar 16;3(3):CD011969. doi: 10.1002/14651858.CD011969.pub2.
8
Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid.我应该继续服用治疗胃酸反流的药物吗?一项评估患者决策辅助工具的前后对照试点研究设计。
Can Pharm J (Ott). 2016 Nov 30;150(1):19-23. doi: 10.1177/1715163516679425. eCollection 2017 Jan-Feb.
9
Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.减少老年人不适当质子泵抑制剂用药的干预措施的有效性
Drugs Aging. 2017 Apr;34(4):265-287. doi: 10.1007/s40266-017-0442-1.
10
Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change.澳大利亚老年人中质子泵抑制剂的使用:国家质量改进计划带来了持续的实践变革。
Int J Qual Health Care. 2017 Feb 1;29(1):75-82. doi: 10.1093/intqhc/mzw138.